editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

Published

Development and validation for Simultaneous Estimation of Alogliptin and Metformin in combined dosage form by UV Method

Published in August 2017 Issue 8 (Vol. 5, Issue 8, 2017)

Development and validation for Simultaneous Estimation of Alogliptin and Metformin in combined dosage form by UV Method - Issue cover

Abstract

A simple, sensitive, accurate and precise simultaneous UV spectrophotometric method has been developed for the estimation of alogliptin and metformin in tablet dosage form. The absorption maxima of the drugs were found to be 225 and 237 nm for alogliptin and metformin, respectively, in methanol, using a Shimadzu UV- visible spectrophotometer (model UV-1650). Alogliptin and metformin in obeyed beer’s law in the range of 0.05-0.25 µg/ml and 2-10 µg/ml, respectively. The correlation co-efficient value for metformin was found to be 0.99963 and 0.99936 at 225 nm and 237 nm, respectively. The correlation co-efficient value for alogliptin was found to be 0.99968 and 0.9333 at 225 nm and 237 nm, respectively. The method was validated for various parameters according to ICH guidelines. The low relative standard deviation values indicate good precision and high recovery values indicate accuracy of the proposed method.

Authors (2)

S.Malathi

Department of Pharmaceutical A...

View all publications →

M.Vijayalakshmi

Department of Pharmaceutical A...

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Article Information

AJPHR508008

AJPHR-01-000626

2017-08-01

Article Impact

Views:2,812
Downloads:1,345

How to Cite

S.Malathi & M.Vijayalakshmi (2017). Development and validation for Simultaneous Estimation of Alogliptin and Metformin in combined dosage form by UV Method. American Journal of Pharmacy and Health Research, 5(8), xx-xx. https://ajphr.com/articles/AJPHR508008

Article Actions

Whatsapp